Prelude Therapeutics
PRLD • NASDAQ
Prelude Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Krishna Vaddi, with a market cap of $277.2M.
Market Cap$277.2M
Employees128.0
CEOKrishna Vaddi
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
Prelude Therapeutics FAQ
Common questions about Prelude Therapeutics
Prelude Therapeutics is scheduled to report earnings for Q1 2026 on May 5, 2026.
Prelude Therapeutics has approximately 128 employees.